Skip to main content
. 2022 Apr 11;9:826729. doi: 10.3389/fcvm.2022.826729

FIGURE 1.

FIGURE 1

Study workflow for the development of a novel ELISA to detect anti-ApoB IgG- and IgM- plasma levels. (1) ApoB-derived peptides with a length of 15 amino acids were screened in silico for their binding affinity to MHC-II variants (18). A pool of 30 peptides that showed a high affinity to MHC-II in direct in vitro affinity measurements were used to coat a microplate at 5 μg/mL. (2) A total of 307 plasma samples from the TRAFIC cohort were analyzed by an in-house chemiluminescent ELISA (3) to detect circulating anti-ApoB IgG and IgM auto-antibodies. The figure was generated with schematics from Biorender.com.